Current Value
$2.931 Year Return
Current Value
$2.931 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TXMD | 42.55% | $13.89M | -41.46% | 0.00% |
ABEO | 36.92% | $318.19M | +38.22% | 0.00% |
NUVL | 35.33% | $5.52B | -3.89% | 0.00% |
ARWR | 35.10% | $2.31B | -35.04% | 0.00% |
IMVT | 34.65% | $2.76B | -36.82% | 0.00% |
ROIV | 34.62% | $7.67B | +4.16% | 0.00% |
LPRO | 34.07% | $271.91M | -65.66% | 0.00% |
ARCT | 32.80% | $337.38M | -59.95% | 0.00% |
NNOX | 32.76% | $344.95M | -30.46% | 0.00% |
RARE | 32.61% | $3.55B | -15.97% | 0.00% |
MODG | 32.59% | $1.44B | -50.51% | 0.00% |
SYNA | 32.49% | $2.49B | -32.28% | 0.00% |
EYPT | 31.91% | $606.23M | -5.47% | 0.00% |
XNCR | 31.67% | $677.55M | -56.77% | 0.00% |
KEYS | 31.53% | $27.97B | +17.66% | 0.00% |
DNLI | 31.32% | $2.21B | -29.48% | 0.00% |
MGTX | 30.80% | $520.77M | +38.17% | 0.00% |
CMBM | 30.31% | $10.05M | -88.70% | 0.00% |
BW | 30.30% | $120.05M | -13.48% | 0.00% |
CMPS | 29.64% | $426.17M | -32.89% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LITB | -11.31% | $21.77M | -74.81% | 0.00% |
PPC | -9.07% | $10.70B | +45.42% | 0.00% |
XGN | -9.02% | $158.67M | +268.53% | 0.00% |
NEXA | -8.62% | $650.28M | -37.13% | 0.00% |
PRGS | -8.04% | $2.71B | +24.76% | 0.28% |
EZPW | -7.27% | $754.24M | +33.11% | 0.00% |
UTZ | -7.00% | $1.16B | -26.39% | 1.79% |
LANC | -6.75% | $4.64B | -9.75% | 2.22% |
SYPR | -6.55% | $44.35M | +2.66% | 0.00% |
COKE | -6.14% | $8.45B | +5.62% | 7.32% |
VHC | -6.14% | $37.77M | +135.71% | 0.00% |
MUSA | -6.11% | $8.20B | -12.51% | 0.46% |
STG | -5.94% | $32.24M | -0.16% | 0.00% |
ACI | -5.17% | $12.25B | +5.30% | 2.53% |
MFIN | -5.12% | - | - | 4.66% |
K | -4.92% | $28.31B | +38.89% | 2.82% |
DFDV | -4.71% | $380.05M | +2,345.35% | 0.00% |
AGRO | -4.67% | $921.94M | +1.43% | 3.75% |
CHD | -4.38% | $24.41B | -6.85% | 1.17% |
LTM | -3.97% | $12.15B | -96.20% | 2.54% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -17.90% | $298.87M | 1.43% |
VIXY | -15.32% | $153.01M | 0.85% |
TAIL | -14.01% | $107.77M | 0.59% |
GBIL | -12.52% | $6.05B | 0.12% |
KCCA | -10.62% | $93.93M | 0.87% |
ULST | -9.81% | $663.99M | 0.2% |
GOVT | -9.41% | $27.27B | 0.05% |
WEAT | -8.32% | $121.10M | 0.28% |
TPMN | -5.79% | $30.67M | 0.65% |
XONE | -5.26% | $634.70M | 0.03% |
JMST | -4.06% | $3.84B | 0.18% |
TFLO | -3.94% | $6.97B | 0.15% |
CLIP | -3.54% | $1.50B | 0.07% |
CORN | -2.99% | $47.42M | 0.2% |
TBLL | -2.25% | $2.26B | 0.08% |
FXE | -1.50% | $547.46M | 0.4% |
FTSD | -1.37% | $228.13M | 0.25% |
CTA | -1.22% | $1.09B | 0.76% |
IVOL | -1.14% | $358.39M | 1.02% |
CMBS | -1.04% | $438.36M | 0.25% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 36.88% | $4.89B | 0.35% |
IBB | 34.87% | $5.23B | 0.45% |
GNOM | 33.84% | $44.34M | 0.5% |
BBH | 31.44% | $334.99M | 0.35% |
PBW | 29.93% | $263.42M | 0.65% |
PFFV | 29.43% | $304.45M | 0.25% |
PFFD | 28.96% | $2.30B | 0.23% |
ARKG | 28.89% | $980.60M | 0.75% |
PBE | 28.60% | $229.19M | 0.58% |
FBT | 28.53% | $1.05B | 0.54% |
YYY | 28.43% | $556.30M | 3.25% |
PINK | 28.25% | $131.18M | 0.5% |
PFF | 27.73% | $13.66B | 0.46% |
PTH | 27.64% | $104.10M | 0.6% |
PBD | 27.58% | $70.67M | 0.75% |
PFXF | 27.46% | $1.79B | 0.4% |
SDIV | 27.30% | $846.36M | 0.58% |
ICLN | 26.13% | $1.41B | 0.41% |
IWMY | 26.10% | $109.69M | 1.02% |
IWO | 26.05% | $11.46B | 0.24% |
Yahoo
Curis Inc (CRIS) reports a reduced net loss and successful financing, while advancing promising clinical studies and welcoming a new Chief Medical Officer.
Yahoo
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Board of Directors of Curis approved the grant of inducement stock options to its newly appointed Chief Medical Officer, Dr. Ahmed Hamdy to purchase 200,000 shares of Curis common stock, with a grant date of May 1, 2025 (the "Inducement Grant").
SeekingAlpha
Curis, Inc. (NASDAQ:CRIS) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ETCompany ParticipantsDiantha Duvall - Chief Financial OfficerJim Dentzer -...
Yahoo
Curis (CRIS) delivered earnings and revenue surprises of -9.65% and 11.74%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Yahoo
LEXINGTON, Mass. AP) — Curis Inc. CRIS) on Tuesday reported a loss of $10.6 million in its first quarter.
Yahoo
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today reported its business update and financial results for the first quarter ended March 31, 2025.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
USDU | 0.21% | $165.88M | 0.5% |
SPTS | 0.26% | $5.78B | 0.03% |
IBTF | -0.33% | $2.07B | 0.07% |
FXY | -0.40% | $857.17M | 0.4% |
UDN | 0.49% | $145.23M | 0.78% |
UNG | -0.51% | $372.51M | 1.06% |
TESL | -0.51% | $31.15M | 1.2% |
TBIL | -0.55% | $5.91B | 0.15% |
UUP | -0.61% | $209.44M | 0.77% |
XHLF | 0.68% | $1.64B | 0.03% |
BILZ | 0.70% | $839.99M | 0.14% |
STOT | 0.85% | $235.94M | 0.45% |
BILS | 1.03% | $3.93B | 0.1356% |
CMBS | -1.04% | $438.36M | 0.25% |
IVOL | -1.14% | $358.39M | 1.02% |
CTA | -1.22% | $1.09B | 0.76% |
FTSD | -1.37% | $228.13M | 0.25% |
FXE | -1.50% | $547.46M | 0.4% |
BIL | 1.56% | $44.07B | 0.1356% |
IBTG | 1.61% | $1.94B | 0.07% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CMPR | -<0.01% | $1.11B | -48.75% | 0.00% |
CNC | <0.01% | $27.50B | -18.37% | 0.00% |
ZCMD | 0.04% | $26.26M | -13.33% | 0.00% |
EIG | -0.04% | $1.13B | +13.03% | 2.59% |
GO | -0.05% | $1.30B | -35.75% | 0.00% |
FYBR | 0.13% | $9.05B | +41.10% | 0.00% |
CHE | -0.19% | $8.03B | +1.40% | 0.36% |
NGVC | 0.20% | $999.95M | +109.27% | 1.08% |
BTCT | 0.21% | $21.81M | +56.22% | 0.00% |
ACEL | 0.22% | $983.53M | +11.84% | 0.00% |
AJG | 0.31% | $80.14B | +20.88% | 0.79% |
ATRC | 0.32% | $1.63B | +49.68% | 0.00% |
MTN | 0.34% | $5.65B | -15.10% | 5.81% |
DSP | 0.38% | $841.52M | +38.23% | 0.00% |
AWK | 0.40% | $27.42B | +9.74% | 2.22% |
TMUS | 0.41% | $262.22B | +32.88% | 1.44% |
RVLV | 0.41% | $1.51B | +17.16% | 0.00% |
KR | -0.42% | $43.03B | +28.80% | 1.97% |
ULS | -0.43% | $14.13B | +71.75% | 0.72% |
AMSF | -0.51% | $860.50M | +12.07% | 3.32% |